nach oben

Erschienen in:

17.01.2017 | Analgetika in der Zahnmedizin | FORTBILDUNG . SCHWERPUNKT

Saisonkrankheit Erkältung

Leitliniengerechte Therapie von Schnupfen und Sinusitis

verfasst von: Dr. med. Nina Dippold, Prof. Dr. med. Ludger Klimek

Erschienen in: MMW - Fortschritte der Medizin | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die meisten grippalen Infekte oder „Erkältungen“ werden durch Viren verursacht — doch selbst bei bakteriellen Infektionen sollte zunächst eine rein symptomatische Behandlung versucht werden. Hierfür stehen hauptsächlich Analgetika, Dekongestiva und pflanzliche Mittel zur Verfügung. Für eine erfolgreiche Therapie müssen diese immer kombiniert werden.

Fokkens, W.J., et al., European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl, 2012(23): p. 3 p preceding table of contents, 1-298.

(DEGAM), D.G.f.A.u.F. Rhinosinusitis - DEGAM - Leitlinie Nr. 10 - Stand 2008. 2008 [cited 2016 Apr 20]; Available from: http://www.awmf.org/uploads/tx_szleitlinien/053-012_S3_Rhinosinusitis_Lang_abgelaufen.pdf.

Aring, A.M. and M.M. Chan, Acute rhinosinusitis in adults. Am Fam Physician, 2011. 83(9): p. 1057–63.PubMed

Meltzer, E.O. and D.L. Hamilos, Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc, 2011. 86(5): p. 427–43.CrossRefPubMedPubMedCentral

Mosges, R. and C.P. Heubach, [What is the evidence for non-antibiotic drug therapy of Rhinosinusitis?]. Laryngorhinootologie, 2011. 90(12): p. 740–6.CrossRefPubMed

Thomas, M., et al., EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 - a summary. Prim Care Respir J, 2008. 17(2): p. 79–89.CrossRefPubMed

Slavin, R.G., et al., The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol, 2005. 116(6 Suppl): p. S13–47.CrossRefPubMed

Heikkinen, T. and A. Jarvinen, The common cold. Lancet, 2003. 361(9351): p. 51–9.CrossRefPubMed

Chow, A.W., et al., IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis, 2012. 54(8): p. e72–e112.CrossRefPubMed

10.

Kim, S.Y., et al., Non-steroidal anti-inflammatory drugs for the common cold. Cochrane Database Syst Rev, 2013. 6: p. CD006362.

11.

Winther, B. and N. Mygind, The therapeutic effectiveness of ibuprofen on the symptoms of naturally acquired common colds. Am J Rhinol, 2001. 15(4): p. 239–42.PubMed

12.

Bachert, C., et al., Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study. Clin Ther, 2005. 27(7): p. 993–1003.CrossRefPubMed

13.

Grebe, W., et al., A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza-like symptoms. Clin Ther, 2003. 25(2): p. 444–58.CrossRefPubMed

14.

Doyle, G., et al., Gastrointestinal safety and tolerance of ibuprofen at maximum over-the-counter dose. Aliment Pharmacol Ther, 1999. 13(7): p. 897–906.CrossRefPubMed

15.

Moore, N., et al., Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC. Expert Opin Drug Saf, 2014. 13(2): p. 167–79.CrossRefPubMed

16.

Whelton, A., Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and non-NSAID analgesics. Am J Ther, 2000. 7(2): p. 63–74.CrossRefPubMed

17.

Moore, N., et al., Tolerability of ibuprofen, aspirin and paracetamol for the treatment of cold and flu symptoms and sore throat pain. Int J Clin Pract, 2002. 56(10): p. 732–4.PubMed

18.

Prescott, L.F., Paracetamol, alcohol and the liver. Br J Clin Pharmacol, 2000. 49(4): p. 291–301.CrossRefPubMedPubMedCentral

19.

Eccles, R., Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu. J Clin Pharm Ther, 2006. 31(4): p. 309–19.CrossRefPubMed

20.

Taverner, D. and J. Latte, Nasal decongestants for the common cold. Cochrane Database Syst Rev, 2007(1): p. CD001953.

21.

Eccles, R., et al., Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold. Am J Rhinol, 2005. 19(1): p. 25–31.PubMed

22.

Latte, J. and D. Taverner, Clinical trial of 3 days of treatment with oral pseudoephedrine for the common cold in the southern hemisphere. Am J Rhinol, 2007. 21(4): p. 452–5.CrossRefPubMed

23.

Sperber, S.J., et al., Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Bull N Y Acad Med, 1989. 65(1): p. 145–60.PubMedPubMedCentral

24.

Taverner, D., C. Danz, and D. Economos, The effects of oral pseudoephedrine on nasal patency in the common cold: a double-blind single-dose placebo-controlled trial. Clin Otolaryngol Allied Sci, 1999. 24(1): p. 47–51.CrossRefPubMed

25.

Eccles, R., et al., Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection. Am J Rhinol, 2007. 21(1): p. 40–5.CrossRefPubMed

26.

Eccles, R., K. Martensson, and S.C. Chen, Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold. Curr Med Res Opin, 2010. 26(4): p. 889–99.CrossRefPubMed

27.

Eccles, R., et al., The nasal decongestant effect of xylometazoline in the common cold. Am J Rhinol, 2008. 22(5): p. 491–6.CrossRefPubMed

28.

Akerlund, A., et al., Nasal decongestant effect of oxymetazoline in the common cold: an objective dose-response study in 106 patients. J Laryngol Otol, 1989. 103(8): p. 743–6.CrossRef

29.

Bickford, L., S. Shakib, and D. Taverner, The nasal airways response in normal subjects to oxymetazoline spray: randomized double-blind placebo-controlled trial. Br J Clin Pharmacol, 1999. 48(1): p. 53–6.CrossRefPubMedPubMedCentral

30.

Dorn, M., W. Hofmann, and E. Knick, [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis]. HNO, 2003. 51(10): p. 794–9.CrossRefPubMed

31.

Katona, G., et al., Treatment of acute rhinitis with a nasal spray containing tramazoline and essential oils: a multicenter, uncontrolled, observational trial. Clin Transl Allergy, 2015. 5: p. 38.CrossRefPubMedPubMedCentral

32.

Hochban, W., H. Althoff, and A. Ziegler, Nasal decongestion with imidazoline derivatives: acoustic rhinometry measurements. Eur J Clin Pharmacol, 1999. 55(1): p. 7–12.CrossRefPubMed

33.

Jones, J.S., et al., A double-blind comparison between oral pseudoephedrine and topical oxymetazoline in the prevention of barotrauma during air travel. Am J Emerg Med, 1998. 16(3): p. 262–4.CrossRefPubMed

34.

Turner, R.B. and P.M. Darden, Effect of topical adrenergic decongestants on middle ear pressure in infants with common colds. Pediatr Infect Dis J, 1996. 15(7): p. 621–4.CrossRefPubMed

35.

Riechelmann, H., et al., [Acute rhinosinusitis in adults—EPOS 2012 Part II]. Laryngorhinootologie, 2013. 92(11): p. 763–76.CrossRefPubMed

36.

Chua, S.S., et al., A controlled clinical trial on the cardiovascular effects of single doses of pseudoephedrine in hypertensive patients. Br J Clin Pharmacol, 1989. 28(3): p. 369–72.CrossRefPubMedPubMedCentral

37.

Bradley, J.G., et al., The effects of pseudoephedrine on blood pressure in patients with controlled, uncomplicated hypertension: a randomized, double-blind, placebo-controlled trial. J Am Board Fam Pract, 1991. 4(4): p. 201–6.PubMed

38.

Beck, R.A., et al., Cardiovascular effects of pseudoephedrine in medically controlled hypertensive patients. Arch Intern Med, 1992. 152(6): p. 1242–5.CrossRefPubMed

39.

Coates, M.L., C.M. Rembold, and B.M. Farr, Does pseudoephedrine increase blood pressure in patients with controlled hypertension? J Fam Pract, 1995. 40(1): p. 22–6.PubMed

40.

Mores, N., et al., No cardiovascular effects of single-dose pseudoephedrine in patients with essential hypertension treated with beta-blockers. Eur J Clin Pharmacol, 1999. 55(4): p. 251–4.CrossRefPubMed

41.

Gordon, R.D., D.M. Ballantine, and A.W. Bachmann, Effects of repeated doses of pseudoephedrine on blood pressure and plasma catecholamines in normal subjects and in patients with phaeochromocytoma. Clin Exp Pharmacol Physiol, 1992. 19(5): p. 287–90.CrossRefPubMed

42.

Laitinen, L.A., et al., A comparison of the bronchodilator action of pseudoephedrine and ephedrine in patients with reversible airway obstruction. Eur J Clin Pharmacol, 1982. 23(2): p. 107–9.CrossRefPubMed

43.

Salerno, S.M., J.L. Jackson, and E.P. Berbano, Effect of oral pseudoephedrine on blood pressure and heart rate: a meta-analysis. Arch Intern Med, 2005. 165(15): p. 1686–94.CrossRefPubMed

44.

Nelson, D.L. and D.R. Gehlert, Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine, 2006. 29(1): p. 49–60.CrossRefPubMed

45.

Fokkens, W., V. Lund, and J. Mullol, EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists}. Rhinology, 2007. 45(2): p. 97–101.PubMed

46.

Jund, R., et al., Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis. Rhinology, 2012. 50(4): p. 417–26.PubMed

47.

Kehrl, W., U. Sonnemann, and U. Dethlefsen, Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial. Laryngoscope, 2004. 114(4): p. 738–42.CrossRefPubMed

48.

Fischer, J. and U. Dethlefsen, Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial. Cough, 2013. 9(1): p. 25.CrossRefPubMedPubMedCentral

49.

Federspil, P., R. Wulkow, and T. Zimmermann, [Effects of standardized Myrtol in therapy of acute sinusitis—results of a double-blind, randomized multicenter study compared with placebo]. Laryngorhinootologie, 1997. 76(1): p. 23–7.CrossRefPubMed

50.

Timmer, A., et al., Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev, 2013. 10: p. CD006323.

51.

Melzer, J., et al., Systematic review of clinical data with BNO-101 (Sinupret) in the treatment of sinusitis. Forsch Komplementmed, 2006. 13(2): p. 78–87.CrossRefPubMed

52.

Maerz, R., C. Ismail, and M. Popp, [Efficacy of a complex combination of five botanical drugs in the treatment of sinusitis.]. Wien Med Wochenschr, 1999. 149: p. 202–208

53.

Kassel, J.C., D. King, and G.K. Spurling, Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev, 2010(3): p. CD006821.

54.

Bollag, U., E. Albrecht, and W. Wingert, Medicated versus saline nose drops in the management of upper respiratory infection. Helv Paediatr Acta, 1984. 39(4): p. 341–5.PubMed

55.

Adam, P., M. Stiffman, and R.L. Blake, Jr., A clinical trial of hypertonic saline nasal spray in subjects with the common cold or rhinosinusitis. Arch Fam Med, 1998. 7(1): p. 39–43.CrossRefPubMed

56.

Slapak, I., et al., Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children. Arch Otolaryngol Head Neck Surg, 2008. 134(1): p. 67–74.CrossRefPubMed

57.

De Sutter, A.I., et al., Oral antihistamine-decongestant-analgesic combinations for the common cold. Cochrane Database Syst Rev, 2012. 2: p. CD004976.

58.

Eccles, R., et al., Efficacy of a paracetamol-pseudoephedrine combination for treatment of nasal congestion and pain-related symptoms in upper respiratory tract infection. Curr Med Res Opin, 2006. 22(12): p. 2411–8.CrossRefPubMed

Titel: Saisonkrankheit Erkältung
Leitliniengerechte Therapie von Schnupfen und Sinusitis
verfasst von: Dr. med. Nina Dippold
Prof. Dr. med. Ludger Klimek
Publikationsdatum: 17.01.2017
Verlag: Springer Medizin
Schlagwörter: Analgetika in der Zahnmedizin
Paracetamol
Acetylsalicylsäure
Ibuprofen
Acetylsalicylsäure
Rhinosinusitis
Erschienen in: MMW - Fortschritte der Medizin / Ausgabe 1/2017
Print ISSN: 1438-3276
Elektronische ISSN: 1613-3560
DOI: https://doi.org/10.1007/s15006-017-9158-8

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Neu im Fachgebiet Allgemeinmedizin

25.04.2024 | Hypotonie | Nachrichten

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Leitliniengerechte Therapie von Schnupfen und Sinusitis

Zusammenfassung

Leitlinien kompakt für die Allgemeinmedizin

Facharzt-Training Allgemeinmedizin

Neu im Fachgebiet Allgemeinmedizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – Richtig schwierig wird es bei Profisportlern

Update Allgemeinmedizin

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Thromboseprophylaxe für besondere Fälle

Antiinfektivum überzeugt in aktueller Studie

Das Wundermittel gegen Diabetes

Sie leidet viel — aber ist sie krank?

Moderne Technologien in der Diabetologie

Bei Lymphödemen bleibt Physiotherapie regressfrei

Leitlinien kompakt für die Allgemeinmedizin

Facharzt-Training Allgemeinmedizin

Neu im Fachgebiet Allgemeinmedizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – Richtig schwierig wird es bei Profisportlern

Update Allgemeinmedizin